Xenon Pharmaceuticals (XENE) Leases: 2019-2025
Historic Leases for Xenon Pharmaceuticals (XENE) over the last 7 years, with Sep 2025 value amounting to $7.0 million.
- Xenon Pharmaceuticals' Leases fell 15.72% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year decrease of 15.72%. This contributed to the annual value of $7.9 million for FY2024, which is 13.64% down from last year.
- According to the latest figures from Q3 2025, Xenon Pharmaceuticals' Leases is $7.0 million, which was down 4.53% from $7.3 million recorded in Q2 2025.
- Xenon Pharmaceuticals' 5-year Leases high stood at $10.4 million for Q4 2022, and its period low was $3.0 million during Q3 2021.
- Over the past 3 years, Xenon Pharmaceuticals' median Leases value was $8.6 million (recorded in 2024), while the average stood at $8.6 million.
- In the last 5 years, Xenon Pharmaceuticals' Leases soared by 285.34% in 2021 and then dropped by 15.72% in 2025.
- Over the past 5 years, Xenon Pharmaceuticals' Leases (Quarterly) stood at $8.1 million in 2021, then increased by 29.17% to $10.4 million in 2022, then fell by 11.66% to $9.2 million in 2023, then fell by 13.64% to $7.9 million in 2024, then dropped by 15.72% to $7.0 million in 2025.
- Its Leases was $7.0 million in Q3 2025, compared to $7.3 million in Q2 2025 and $7.6 million in Q1 2025.